Evaluation of HIF-1α and VEGF-A expression in radiation-induced cystitis: A case-control study
Int. braz. j. urol
; 47(2): 295-305, Mar.-Apr. 2021. tab, graf
Article
de En
| LILACS
| ID: biblio-1154442
Bibliothèque responsable:
BR1.1
ABSTRACT
ABSTRACT The standard treatment for locally advanced cervical cancer (CC) is chemoradiotherapy. Once the bladder receives part of the radiation, a typical inflammatory condition that configures radiation-induced cystitis may develop. Chronic radiation-induced cystitis is commonly characterized by the bladder new submucosal vascularization, which is typically fragile and favors hematuria. The current study aims to investigate if Hypoxia-Induced Factor (HIF-1α) and its transcriptional target Vascular Endothelial Growth Factor A (VEGF-A) could be a primary pathway leading to increased submucosal vascularization. HIF-1α and VEGF-A mRNA levels in bladder core biopsies from CC patients treated with radiotherapy versus untreated (non-irradiated) patients were analyzed using a droplet digital polymerase chain reaction technology. Gene expression results showed that HIF-1α and VEGF-A had no significant differences between bladder samples from patients previously irradiated and untreated patient samples. However, a direct relationship between the degree of late morbidity and the expression of HIF-1α and VEGF-A has been demonstrated. Despite the lack of statistical significance precludes a definitive conclusion, the data presented herein suggests that further studies investigating the role of HIF-1α in bladder neovascularization in radiation-induced cystitis are highly recommended.
Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Tumeurs du col de l'utérus
/
Cystite
Type d'étude:
Observational_studies
Limites du sujet:
Female
/
Humans
langue:
En
Texte intégral:
Int. braz. j. urol
Thème du journal:
UROLOGIA
Année:
2021
Type:
Article